BTCRC-GI21-500

A Phase II Study of Peri-Operative NovoTTF-200T(P) in Combination with Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI21-500

Currently Enrolling

All sites in which the trial BTCRC-GI21-500 being conducted in.